US OptionsDetailed Quotes
MRNA240816P76000
- 0.22
- -0.20-47.62%
15min DelayClose Aug 13 16:00 ET
0.35High0.02Low
0.31Open0.42Pre Close23 Volume750 Open Interest76.00Strike Price543.00Turnover61.07%IV8.59%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.22Extrinsic Value100Contract SizeAmericanOptions Type-0.0645Delta0.0259Gamma592.14Leverage Ratio-0.0803Theta-0.0005Rho-38.19Eff Leverage0.0100Vega
Moderna Stock Discussion
Sign in to post a comment
$Novavax (NVAX.US)$ $Sanofi (SNY.US)$ $Moderna (MRNA.US)$ $Pfizer (PFE.US)$
As reported by Forbes. The Novavax updated vaccine is much superior to the the moderna and Pfizer. It creates 48x antibodies while Moderna and Pfizer created 7x or 8x only.
Why? The answer is imprinting. Once you get a shot of Wuhan mRNA vaccine the body remembers it and will always produce antibodies agai...
As reported by Forbes. The Novavax updated vaccine is much superior to the the moderna and Pfizer. It creates 48x antibodies while Moderna and Pfizer created 7x or 8x only.
Why? The answer is imprinting. Once you get a shot of Wuhan mRNA vaccine the body remembers it and will always produce antibodies agai...
11
1
Morning Movers
Gapping up
(None listed)
Gapping down
$BioNTech (BNTX.US)$ shares fell 3.2% after the company's second-quarter earnings came in below expectations, with COVID-19 vaccine sales continuing to decline.
$Apple (AAPL.US)$ stock dropped 7.1% following news that Warren Buffett's Berkshire Hathaway sold almost half of its position in the company as part of a wider stock selloff.
$NVIDIA (NVDA.US)$ shares decreased by 12% ...
Gapping up
(None listed)
Gapping down
$BioNTech (BNTX.US)$ shares fell 3.2% after the company's second-quarter earnings came in below expectations, with COVID-19 vaccine sales continuing to decline.
$Apple (AAPL.US)$ stock dropped 7.1% following news that Warren Buffett's Berkshire Hathaway sold almost half of its position in the company as part of a wider stock selloff.
$NVIDIA (NVDA.US)$ shares decreased by 12% ...
35
1
It was a red day for the market after Meta's earnings beat was quickly swept aside by morning earnings calls that hurt investor feelings. Most equities fell on the US market, including the most popular stocks searched on moomoo last week.
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ fell 1.37%, the $Dow Jones Industrial Average (.DJI.US)$ fell 1.21%, and the $Nasdaq Composite Index (.IXIC.US)$ fell 2.30%.
MACRO
Thursday, according ...
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ fell 1.37%, the $Dow Jones Industrial Average (.DJI.US)$ fell 1.21%, and the $Nasdaq Composite Index (.IXIC.US)$ fell 2.30%.
MACRO
Thursday, according ...
+1
32
6
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Good morning, traders. Happy Thursday, August 1st. Earnings and FOMC dovish comments almost brought the market toward another positive day, but the market went negative right after 10 am. Today is yet another major earnings day, with $Apple (AAPL.US)$, $Amazon (AMZN.US)$, and more.
My name is Kevin Travers; I am trying out new names for this podcast before launching on Spotify, let me know what you think. Here are stories from the ...
My name is Kevin Travers; I am trying out new names for this podcast before launching on Spotify, let me know what you think. Here are stories from the ...
43
15
If I had any sway over the $Novavax (NVAX.US)$ board, my suggestions would be…
- Focus now on the SARS CoV-2 FLiRT variant and be ready to say yes to the FDA when the call for development is made. Don’t have a repeat episode where your competitors $Moderna (MRNA.US)$ and $Pfizer (PFE.US)$ pick up the exciting strains (KP) whilst you’re left with the soon to be irrelevant JN strain
- Drive the malaria vaccine harder - go beyond Africa, talk traveller markets, hit GAVI hard, build an access case for ...
- Focus now on the SARS CoV-2 FLiRT variant and be ready to say yes to the FDA when the call for development is made. Don’t have a repeat episode where your competitors $Moderna (MRNA.US)$ and $Pfizer (PFE.US)$ pick up the exciting strains (KP) whilst you’re left with the soon to be irrelevant JN strain
- Drive the malaria vaccine harder - go beyond Africa, talk traveller markets, hit GAVI hard, build an access case for ...
7
2
Morning Movers
Gapping up
$Meta Platforms (META.US)$ stock rose 8.9% following stronger-than-expected second-quarter earnings and a positive future outlook.
$ConocoPhillips (COP.US)$ stock increased by 0.8% after reporting a second-quarter profit that surpassed estimates, aided by higher output and oil prices.
$Ferrari (RACE.US)$ stock climbed 3.3% as the company raised its full-year revenue and core earnings forecasts, having ex...
Gapping up
$Meta Platforms (META.US)$ stock rose 8.9% following stronger-than-expected second-quarter earnings and a positive future outlook.
$ConocoPhillips (COP.US)$ stock increased by 0.8% after reporting a second-quarter profit that surpassed estimates, aided by higher output and oil prices.
$Ferrari (RACE.US)$ stock climbed 3.3% as the company raised its full-year revenue and core earnings forecasts, having ex...
30
3
News Highlights
$NVIDIA (NVDA.US)$ stock fell 1.30%. Its options trading volume was 2.62 million. Call contracts account for 61.5% of the total trading volume.
$Pfizer (PFE.US)$ stock fell 0.16%. Its options trading volume was 0.30 million. Call contracts account for 57.8% of the total trading volume.The $24 calls expiring August 16 were traded most actively.
Pfizer, $GlaxoSmithKline (GSK.US)$, and $Moderna (MRNA.US)$ are in a ...
$NVIDIA (NVDA.US)$ stock fell 1.30%. Its options trading volume was 2.62 million. Call contracts account for 61.5% of the total trading volume.
$Pfizer (PFE.US)$ stock fell 0.16%. Its options trading volume was 0.30 million. Call contracts account for 57.8% of the total trading volume.The $24 calls expiring August 16 were traded most actively.
Pfizer, $GlaxoSmithKline (GSK.US)$, and $Moderna (MRNA.US)$ are in a ...
+2
27
1
$Moderna (MRNA.US)$ it broke out a few months ago and it's retesting the key MA/EMA lines and seems to be holding above support so it could be a potential swing trade here and ride it back to the 170-180s and sell there again
or you can wait for earnings it's only 2 weeks away
or you can wait for earnings it's only 2 weeks away
2
1
No comment yet
Stock Winner : Thks for ur sharing